CAMP4 Therapeutics Corporation (NASDAQ:CAMP) Short Interest Update

CAMP4 Therapeutics Corporation (NASDAQ:CAMP) saw a significant increase in short interest in the month of April. As of April 15th, there was short interest totaling 468,369 shares, an increase of 13.1% from the March 31st total of 414,235 shares. Currently, 1.4% of the shares of the company are short sold. Based on an average daily volume of 72,037 shares, the days-to-cover ratio is currently 6.5 days.

Institutional Trading of CAMP4 Therapeutics

A number of institutional investors have recently added to or reduced their stakes in the stock. Janus Henderson Group PLC boosted its holdings in CAMP4 Therapeutics by 35.9% during the fourth quarter. Janus Henderson Group PLC now owns 6,307,636 shares of the Wireless communications provider’s stock worth $38,807,000 after buying an additional 1,666,666 shares in the last quarter. EcoR1 Capital LLC purchased a new stake in CAMP4 Therapeutics during the fourth quarter worth about $1,992,000. Balyasny Asset Management L.P. purchased a new stake in CAMP4 Therapeutics during the fourth quarter worth about $14,938,000. 683 Capital Management LLC purchased a new stake in CAMP4 Therapeutics during the fourth quarter worth about $775,000. Finally, Adage Capital Partners GP L.L.C. boosted its holdings in CAMP4 Therapeutics by 11.3% during the fourth quarter. Adage Capital Partners GP L.L.C. now owns 2,181,679 shares of the Wireless communications provider’s stock worth $13,374,000 after buying an additional 220,895 shares in the last quarter.

Wall Street Analyst Weigh In

A number of research analysts have commented on CAMP shares. Cantor Fitzgerald restated an “overweight” rating on shares of CAMP4 Therapeutics in a research note on Friday, March 6th. Leerink Partners lifted their price objective on shares of CAMP4 Therapeutics from $8.00 to $9.00 and gave the company an “outperform” rating in a research note on Thursday, April 2nd. Finally, Rodman & Renshaw started coverage on shares of CAMP4 Therapeutics in a report on Tuesday, April 14th. They issued a “buy” rating and a $7.00 target price on the stock. Five equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $8.60.

CAMP4 Therapeutics Stock Down 2.9%

Shares of NASDAQ:CAMP opened at $4.05 on Friday. The company has a market cap of $210.30 million, a price-to-earnings ratio of -1.52 and a beta of 0.04. The firm’s 50-day simple moving average is $4.66 and its 200-day simple moving average is $4.59. CAMP4 Therapeutics has a fifty-two week low of $1.30 and a fifty-two week high of $7.75.

CAMP4 Therapeutics (NASDAQ:CAMP) last issued its earnings results on Thursday, March 5th. The Wireless communications provider reported ($0.87) earnings per share for the quarter, missing the consensus estimate of ($0.31) by ($0.56). The firm had revenue of $0.35 million during the quarter. CAMP4 Therapeutics had a negative net margin of 2,298.54% and a negative return on equity of 162.49%. On average, research analysts forecast that CAMP4 Therapeutics will post -0.78 EPS for the current year.

CAMP4 Therapeutics Company Profile

CalAmp Corp., a connected intelligence company, provides leverages a data-driven solutions ecosystem to people and organizations in the United States, Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and internationally. The company operates in two segments, Software & Subscription Services and Telematics Products. It provides CalAmp Telematics Cloud platform, such as cloud-based application enablement and telematics service platforms that facilitate integration of its own applications, as well as those of third parties, through open application programming interfaces; and software as a service application, as well as provides tracking and monitoring services within fleet management, supply chain integrity, and international vehicle location.